Senator Bernie Sanders is intensifying efforts to reduce the cost of Ozempic, a blockbuster drug produced by Novo Nordisk. Sanders has expressed his desire to meet with Novo Nordisk's top executive next week to discuss lowering the drug's price, as reported by @bpolitics. His actions underscore a broader critique against pharmaceutical companies for their pricing practices, accusing them of price gouging and stating 'People Are Sick and Tired of Being Ripped Off!'. Despite Sanders' persistent advocacy for more affordable drug pricing, skepticism remains about the impact of political pressure on Novo Nordisk's pricing strategies.
Ozempic from Novo Nordisk is the latest target in Sen. Bernie Sanders’ quest to lower drug costs, but it’s unlikely the political pressure campaign will make a dent on the manufacturer to slash prices. https://t.co/EFUiYYZBVs
Senator Bernie Sanders wants to with Novo Nordisk’s top executive about lowering the price of its blockbuster drug Ozempic, per Bloomberg.
Bernie Sanders Accuses Ozempic Manufacturer of Massive Price Gouging: 'People Are Sick and Tired of Being Ripped Off!' https://t.co/SwifZskUX9
Sanders is currently trying to meet with Novo Nordisk’s CEO and turn up the heat on Ozempic, but the grassroots needs to get involved again too. The idea that these companies can just demand whatever dollar amount they want is absurd, and it’s time we stopped putting up with it. https://t.co/SoOmvfm9xf
Senator Bernie Sanders wants to meet next week with Novo Nordisk’s top executive about lowering the price of its blockbuster drug Ozempic. https://t.co/hsfkaa15Ix via @bpolitics
Bernie Sanders Demands Cheaper Ozempic https://t.co/oHZumgBGmL